)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Respiratorius (RESP) investor relations material
Respiratorius Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary12 Aug, 2025
Executive summary
No revenue generated in H1 2025; net loss after financial items was -3,811 KSEK compared to -3,571 KSEK year-over-year.
Scientific publication and patent progress for lead candidate VAL001, targeting DLBCL.
FDA granted a pre-IND meeting for VAL001, advancing regulatory pathway for US market.
Market research indicates strong physician interest in VAL001, with over 70% willing to prescribe if available.
Rights issue of up to 18.9 MSEK announced post-period to strengthen financial position and support VAL001 development.
Financial highlights
Net sales were 0 KSEK for both Q2 and H1 2025, unchanged year-over-year.
Net loss after financial items was -1,805 KSEK in Q2 2025 (vs. -1,810 KSEK Q2 2024); H1 net loss was -3,811 KSEK (vs. -3,571 KSEK H1 2024).
Earnings per share improved to -0.75 SEK for H1 2025 from -1.22 SEK year-over-year.
Cash and cash equivalents at period end were 3,129 KSEK, down from 7,646 KSEK at 2024 year-end.
Equity ratio (soliditet) increased to 96.12% at June 30, 2025, from 91.48% a year earlier.
Outlook and guidance
Rights issue aims to fund operations until cash flow positivity, expected via a licensing deal for VAL001.
Next steps include advancing VAL001 to phase III and pursuing commercialization.
VAL001 FDA pre-IND meeting outcome?
VAL001 projected annual sales?
Purpose of recent share issue?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Respiratorius earnings date
Q3 202511 Nov, 2025
Next Respiratorius earnings date
Q3 202511 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Respiratorius AB is a Swedish biotechnology company focused on developing drug candidates for the treatment of various diseases, primarily cancer, COPD (Chronic Obstructive Pulmonary Disease), and asthma. Its lead project, VAL001, is aimed at enhancing the treatment of Diffuse Large B-Cell Lymphoma (DLBCL), the most common type of aggressive lymphoma. Additionally, the company is developing substances like the RESP series, which have bronchodilating effects for respiratory conditions such as COPD and asthma. Respiratorius is also working on a cardiovascular biomarker to aid in PET imaging diagnostics. The company is headquartered in Lund, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage